Anika Therapeutics, Inc. Earnings Per Share Diluted

• Anika Therapeutics, Inc. showed an increase of +80.2% in Earnings Per Share Diluted from 2024 to 2025.
• This data is from Anika Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 3, 2026.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 17 years of available data (2009 to 2025), Anika Therapeutics, Inc.'s Earnings Per Share Diluted has declined by 337.5%.
• Historical annual values: Fiscal year 2025: $0.76 (loss) per share | Fiscal year 2024: $3.83 (loss) per share | Fiscal year 2023: $5.64 (loss) per share | Fiscal year 2022: $1.02 (loss) per share | Fiscal year 2021: $0.28 per share | Fiscal year 2020: $1.69 (loss) per share | Fiscal year 2019: $1.89 per share | Fiscal year 2018: $1.27 per share | Fiscal year 2017: $2.11 per share | Fiscal year 2016: $2.15 per share | Fiscal year 2015: $2.01 per share | Fiscal year 2014: $2.51 per share | Fiscal year 2013: $1.39 per share | Fiscal year 2012: $0.82 per share | Fiscal year 2011: $0.62 per share | Fiscal year 2010: $0.32 per share | Fiscal year 2009: $0.32 per share.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026